Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TrialScope
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TrialScope
-
#Clinicaltrial sponsors can put#patientengagement and#transparency into practice with plain language summaries. This PLS webinar features experts from Jazz Pharmaceuticals, ClaritiDox and TrialScope.#PlainLanguageSummaries@JazzPharma Register today: http://ow.ly/NAHi50yegjh pic.twitter.com/4CSMhrSMCh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As this article indicates, global
#clinicaltrial regulations are complex. Each country's registry has different timelines and data requirements. Plus, there no single standard on how data is captured and reported. At TrialScope, we help manage it all.http://ow.ly/akya50yebCqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The first
@PatientPower Cancer Clinical Trials survey shows that most patients are interested in taking part in clinical trials. However, 43% of all patients surveyed reported that their medical teams never discussed#clinicaltrials with them.http://ow.ly/dZ8e50yeb5RHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It's Patient Recognition Week, and we'd like to thank all the patients who participate in
#clinicaltrial research.#PatientRecognitionWeekpic.twitter.com/J85JGWdMFj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Global
#clinicaltrial recruitment rates have been on the rise over the past seven years, thanks to new techniques designed to make patient participation easier, but the benefits have not translated to patient retention, according to a new study. http://ow.ly/NibB50ybUlI pic.twitter.com/KoIBi6IoOW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Jazz Pharmaceuticals, ClaritiDox and TrialScope for an information-packed webinar on plain language summaries. Hear how to set up a successful PLS program, best practices, trends and more.
#PlainLanguageSummaries@JazzPharma http://ow.ly/MdkM50y8oXV pic.twitter.com/88qj0lg9ne
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out the first in an 8-part series on
#clinicaltrial transparency policies, by Thomas Wicks, Chief Strategy officer.@ThomasWicksPCM http://ow.ly/VEeh50y7d7p pic.twitter.com/GSnornsCCZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mike Wenger, Vice President of Patient Engagement, looks into his crystal ball and makes a few predictions on where healthcare tech is headed in 2020. What does he see? For starters, API adoption.
#healthcaretech@njtechwklyhttp://ow.ly/Gq0M50y75TQHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With a focus on collaboration, this webinar reveals how EMD Serono, TrialScope and CISCRP worked together to launch the EMD Serono
#clinicaltrials website.@EMDSerono@CISCRP#healthliteracy Now available on demand:http://ow.ly/qoEC50y4pdBHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Patients don't participate in
#clinicaltrials due to lack of education/awareness, access & financial issues. The Leukemia & Lymphoma Society Clinical Trial Support Center, in conjunction with the American Hematology Society, seeks to change that.@LLSusa http://ow.ly/8Fni50y4b2L pic.twitter.com/ONA9XeMPVp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mike Wenger, TrialScope VP of Patient Engagement, discusses access to
#clinicaltrials and#patientengagement at the CBI conference in Miami.@wanderingwengerpic.twitter.com/z16QmuUPjw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thomas Wicks, TrialScope Chief Strategy Officer, moderates a discussion on data and
#patientengagement at CBI's conference in Miami. He's joined by Jo Anne-Marie Blyskal, Teva; Danielle Leach, National Brain Tumor Society; and Mike Wenger, TrialScope VP of Patient Engagement.pic.twitter.com/vbJOlq4Kan
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Thomas Wicks, Mike Wenger and Jaclyn Spedaliere are representing TrialScope at the CBI conference in Coral Gables. At 11:30, Thomas will moderate a panel discussion: "Elevate Patient Engagement through Improved Access of Clinical Information." Don't miss it!
@CBI_Conferencespic.twitter.com/3mVUOuDVpf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Healthliteracy is essential to quality healthcare. Low health literacy can be costly for patients, payers and providers - to the tune of $4.8 billion a year for payers, says a 2018 study. Health literacy can also have serious patient safety implications.http://ow.ly/W2vk50y1fYiHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See how Merck KGaA made transparency a priority with its EMD Serono
#clinicaltrials website. CISCRP collaborated to ensure that content was patient-friendly. TrialScope Engage technology completes the trifecta.@EMDSerono@CISCRP Register now: http://ow.ly/RCsX50y0RYe pic.twitter.com/HcA1HCSbbv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Penn State Cancer Institute researchers analyzed data from over 12 million patients with 46 different types of cancer between 2004 and 2015. They found that only 0.1% were enrolled in
#clinicaltrials as their first course of therapy following diagnosis.http://ow.ly/CsKN50y0aBDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The degree of digital
#healthliteracy – of physicians, patients, institutions and payers – can really make the difference between an efficient integration and a missed opportunity, says one#healthcare communications professional.http://ow.ly/QhF050y0599Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Clinicaltrial transparency still eludes the system in India, especially for the patient, says the president of the Indian Society for Clinical Research and advocacy groups.http://ow.ly/URfv50xZXNpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Failure to report
#clinicaltrial results on http://ow.ly/nAQy50xZV1s distorts evidence, breaches ethical obligations, and represents research waste. See how industry/non-industry, large/small sponsors fared in this comprehensive study.@bengoldacre http://ow.ly/cRwO50xZV1r pic.twitter.com/ijnFir2fKn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.